Latest Impairment News

Page 48 of 54
Westpac Banking Corporation reported a 9% decline in net profit for the first half of 2025, reflecting margin compression and higher costs, while advancing its digital transformation and sustainability agenda.
Claire Turing
Claire Turing
7 May 2025
National Australia Bank (NAB) reported steady cash earnings and improved return on equity in the first half of 2025, underpinned by strong capital ratios and a clear strategic focus on business banking, deposits, and proprietary home lending.
Claire Turing
Claire Turing
7 May 2025
National Australia Bank posted a 0.8% rise in cash earnings for 1H25, underpinned by profit growth and lower credit impairments amid a cautious economic outlook. The bank advances its strategy focused on customer experience and technology modernization while maintaining strong capital and liquidity positions.
Claire Turing
Claire Turing
7 May 2025
National Australia Bank’s half year results to March 2025 reveal modest revenue growth and stable cash earnings amid competitive pressures and regulatory demands. The bank’s strong capital position and ongoing strategy execution underpin cautious optimism.
Claire Turing
Claire Turing
7 May 2025
Bega Group is consolidating its Strathmerton cheese operations into its Ridge Street site by mid-2026, targeting significant cost savings and operational efficiencies.
Victor Sage
Victor Sage
6 May 2025
Aurizon reports a mixed freight volume performance to April 2025 alongside progress on $50 million in annualised cost savings and a potential subordinated hybrid capital raise.
Victor Sage
Victor Sage
6 May 2025
Citigold Corporation Limited has faced intense ASX scrutiny following an adverse auditor opinion on its half-year financials, centering on a $20 million impairment of exploration assets. The company defends its valuation approach despite funding uncertainties and regulatory questions.
Maxwell Dee
Maxwell Dee
5 May 2025
Endeavour Group reports a challenging Q3 with Retail sales down 3.1% and Hotels up 5.1%, while announcing Jayne Hrdlicka as incoming CEO and maintaining capital and finance guidance.
Victor Sage
Victor Sage
5 May 2025
Alterity Therapeutics has secured FDA Fast Track designation for ATH434, its lead candidate for treating Multiple System Atrophy, potentially speeding up regulatory review and bringing hope to patients with this rare neurodegenerative disorder.
Ada Torres
Ada Torres
5 May 2025
Westpac Banking Corporation posted a $3.5 billion net profit for the first half of 2025, maintaining strong capital ratios and advancing its digital transformation and sustainability initiatives despite a slight earnings dip.
Claire Turing
Claire Turing
5 May 2025
Westpac Banking Corporation posted a slight 1% decline in net profit for the first half of 2025, underpinned by strong growth in business and institutional lending and a resilient balance sheet amid global volatility.
Victor Sage
Victor Sage
5 May 2025
Westpac Banking Corporation reported a modest 1% decline in net profit to AUD 3.317 billion for the six months ended March 2025, maintaining its interim dividend and advancing key digital and sustainability initiatives.
Claire Turing
Claire Turing
5 May 2025